Ratings and dated fundamentals
Exact eligible report scores in ranking order. Ratings summarize dated reports, not future returns; report and market dates remain in the table. Showing the first 10 of 91 recorded values; the complete table remains available below.
See the complete ratings and dated fundamentals
Scroll sideways to compare all columns. Select a heading to sort.
| 1 | Intuitive Surgical Inc. | ISRG | 4 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $452.8 | $156,960,275,510.4 | 53.08 | 9.74 |
| 2 | CONMED Corporation | CNMD | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $51.5 | $1,534,871,134.5 | 20.9 | 1.45 |
| 3 | DexCom, Inc. | DXCM | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $79.41 | $29,616,032,716.02 | 29.88 | 11.68 |
| 4 | Electromed, Inc. | ELMD | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $27.17 | $227,308,648.71 | 20.11 | 4.21 |
| 5 | GLOBUS MEDICAL INC | GMED | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $71.05 | $9,539,308,989.7 | 17.11 | 1.99 |
| 6 | InMode Ltd. Ordinary Shares | INMD | 3.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $13.33 | $767,063,812.76 | 8.17 | 1.12 |
| 7 | LivaNova PLC Ordinary Shares | LIVN | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $89.99 | $4,957,261,941.91 | 25.28 | 3.61 |
| 8 | Medtronic plc | MDT | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $101.8 | $130,216,237,202 | 24.89 | 2.56 |
| 9 | Insulet Corporation | PODD | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $146.51 | $10,163,551,509.93 | 23.7 | 6.44 |
| 10 | Stryker Corporation | SYK | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $325.87 | $124,055,777,473.48 | 34.24 | 5.29 |
| 11 | Tactile Systems Technology, Inc. | TCMD | 3.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $26.03 | $583,107,739.19 | 24.48 | 2.57 |
| 12 | Zimmer Biomet Holdings, Inc. | ZBH | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $105.59 | $19,983,318,033.92 | 26.04 | 1.57 |
| 13 | Inspire Medical Systems, Inc. | INSP | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $63.98 | $1,853,252,293.62 | 18.4 | 2.24 |
| 14 | Pro-Dex Inc New | PDEX | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $63.16 | $202,096,063.16 | 16.8 | 4.1 |
| 15 | Penumbra, Inc. | PEN | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $319.21 | $12,581,465,835.85 | 80.13 | 7.95 |
| 16 | Smith & Nephew plc | SNN | 3 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $31.15 | $13,670,564,460.88 | 21.87 | 2.58 |
| 17 | TransMedics Group, Inc. Common Stock | TMDX | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $88.24 | $3,064,917,835.92 | 21.22 | 5.57 |
| 18 | Viemed Healthcare, Inc. Common Shares | VMD | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $9.13 | $345,963,948.22 | 22.14 | 2.28 |
| 19 | AtriCure, Inc. | ATRC | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $58.54 | $2,980,990,446.82 | 200.29 | 5.59 |
| 20 | Baird Medical Investment Holdings Ltd Ordinary Share | BDMD | 2.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $0.09 | $2,825,894.72 | Not reported | 0.09 |
| 21 | Bioventus Inc. Class A Common Stock | BVS | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $10.61 | $892,214,846.8 | 15.57 | 3.06 |
| 22 | iRhythm Holdings, Inc. Common Stock | IRTC | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $90.22 | $3,033,029,132.12 | Not reported | 17.13 |
| 23 | Anbio Biotechnology Class A Ordinary Shares | NNNN | 2.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $3.89 | $170,736,768 | 26.66 | 5.66 |
| 24 | Neuropace, Inc. Common Stock | NPCE | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $12.5 | $429,053,425 | Not reported | 36.11 |
| 25 | PROCEPT BioRobotics Corporation Common Stock | PRCT | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $20.62 | $1,186,394,815.02 | Not reported | 3.61 |
| 26 | SI-BONE, Inc. Common Stock | SIBN | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $24.24 | $1,093,541,228.88 | Not reported | 5.92 |
| 27 | SANUWAVE Health, Inc. Common Stock | SNWV | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.19 | $18,839,056.71 | 1.32 | 6.76 |
| 28 | Sensus Healthcare, Inc | SRTS | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.86 | $47,081,488.74 | Not reported | 1.28 |
| 29 | Xtant Medical Holdings, Inc. | XTNT | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.29 | $40,599,335.62 | Not reported | 1.01 |
| 30 | AngioDynamics, Inc. | ANGO | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $11.73 | $493,298,698.5 | Not reported | 3.01 |
| 31 | Apyx Medical Corporation Common Stock | APYX | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.93 | $123,423,387.39 | Not reported | 12.3 |
| 32 | Accuray Incorporated | ARAY | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.11 | $13,138,323.77 | Not reported | 0.32 |
| 33 | Alphatec Holdings, Inc. | ATEC | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $7.44 | $1,154,240,290.56 | Not reported | Not reported |
| 34 | Beta Bionics, Inc. Common Stock | BBNX | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $15.7 | $853,562,951.9 | Not reported | 2.13 |
| 35 | CeriBell, Inc. Common Stock | CBLL | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $26.59 | $1,032,622,915.9 | Not reported | 8.79 |
| 36 | Cerus Corp | CERS | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.02 | $407,947,451.68 | Not reported | 5.34 |
| 37 | CVRx, Inc. Common Stock | CVRX | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.87 | $24,744,936.01 | Not reported | 1.79 |
| 38 | electroCore, Inc. Common Stock | ECOR | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $7.25 | $66,888,543.5 | Not reported | Not reported |
| 39 | Inogen Inc | INGN | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $6.03 | $160,026,172.11 | Not reported | 0.92 |
| 40 | OrthoPediatrics Corp. Common Stock | KIDS | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $31.76 | $829,268,717.76 | Not reported | 2.44 |
| 41 | Kestra Medical Technologies, Ltd. Common Stock | KMTS | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $28.8 | $1,715,379,696 | Not reported | 7.71 |
| 42 | Pulmonx Corporation Common Stock | LUNG | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.56 | $111,489,702.4 | Not reported | 3.26 |
| 43 | Myomo Inc. | MYO | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.21 | $47,925,503.34 | Not reported | 8.22 |
| 44 | InspireMD, Inc. | NSPR | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.7 | $32,356,426.13 | Not reported | 1.03 |
| 45 | NovoCure Limited Ordinary Shares | NVCR | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $13.28 | $1,552,643,935.52 | Not reported | 4.43 |
| 46 | Orthofix Medical Inc. Common Stock (DE) | OFIX | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $7.87 | $320,565,624.96 | Not reported | 0.75 |
| 47 | Pulse Biosciences, Inc Common Stock (DE) | PLSE | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $53.29 | $3,919,422,159.96 | Not reported | 21.35 |
| 48 | Profound Medical Corp. Common Stock | PROF | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $7.21 | $264,079,545.24 | Not reported | 6.21 |
| 49 | Sight Sciences, Inc. Common Stock | SGHT | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $10.08 | $560,236,088.16 | Not reported | 11.4 |
| 50 | Sanara MedTech Inc. Common Stock | SMTI | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $31.55 | $289,882,504.25 | Not reported | 36.53 |
| 51 | Neuronetics, Inc. Common Stock | STIM | 2 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $2.15 | $167,115,868.65 | Not reported | 7.46 |
| 52 | Stereotaxis, Inc. Common Stock | STXS | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.09 | $109,220,374.02 | Not reported | 6.25 |
| 53 | TELA Bio, Inc. Common Stock | TELA | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.82 | $36,813,700.74 | Not reported | Not reported |
| 54 | Tandem Diabetes Care, Inc. | TNDM | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $16.91 | $1,180,213,935.86 | Not reported | 8.74 |
| 55 | Exagen Inc. Common Stock | XGN | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $5.81 | $140,749,219.59 | Not reported | 11.52 |
| 56 | Autonomix Medical, Inc. Common Stock | AMIX | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.52 | $1,475,985.36 | Not reported | 0.47 |
| 57 | Heartbeam, Inc. Common Stock | BEAT | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.4 | $22,652,366.74 | Not reported | 2.77 |
| 58 | Bluejay Diagnostics, Inc. Common Stock | BJDX | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.35 | $1,165,414.35 | Not reported | 0.12 |
| 59 | BIOMERICA INC | BMRA | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.61 | $7,404,338.48 | Not reported | 2.03 |
| 60 | ClearPoint Neuro, Inc. Common Stock | CLPT | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $8.6 | $275,666,704.8 | Not reported | 10.11 |
| 61 | Cytosorbents Corp. | CTSO | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $4.8 | $15,082,257.6 | Not reported | Not reported |
| 62 | Femasys Inc. Common Stock | FEMY | 1.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $1.37 | $4,142,834.79 | Not reported | 1.03 |
| 63 | Vyome Holdings, Inc. Common Stock | HIND | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.58 | $11,089,274.24 | Not reported | 1.52 |
| 64 | Hyperfine, Inc. Class A Common Stock | HYPR | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.72 | $76,302,017.35 | Not reported | 2.08 |
| 65 | IceCure Medical Ltd. Ordinary Shares | ICCM | 1.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $0.68 | $3,157,345.95 | Not reported | 0.35 |
| 66 | SeaStar Medical Holding Corporation Common Stock | ICU | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.88 | $8,284,861.08 | Not reported | 1.93 |
| 67 | Iridex Corp | IRIX | 1.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $0.66 | $11,547,173.15 | Not reported | 3.17 |
| 68 | LENSAR, Inc. Common Stock | LNSR | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $5.45 | $66,957,964.25 | 1.93 | 2.33 |
| 69 | Microbot Medical, Inc. Common Stock | MBOT | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.11 | $74,552,929.11 | Not reported | 1.08 |
| 70 | Milestone Scientific, Inc. Common Stock | MLSS | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.3 | $26,799,233.87 | Not reported | 7.72 |
| 71 | Modular Medical, Inc. Common Stock | MODD | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.33 | $10,840,594.59 | Not reported | 1.01 |
| 72 | NeuroOne Medical Technologies Corporation Common Stock | NMTC | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.88 | $8,003,965.68 | Not reported | 2.12 |
| 73 | Neuraxis, Inc. | NRXS | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $6.24 | $78,360,453.6 | Not reported | 11.63 |
| 74 | Nuwellis, Inc. Common Stock | NUWE | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $4.58 | $292,332.24 | Not reported | Not reported |
| 75 | enVVeno Medical Corporation Common Stock | NVNO | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $6.73 | $4,676,178.98 | Not reported | 0.28 |
| 76 | Nexalin Technology, Inc. Common Stock | NXL | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.47 | $1,079,784.09 | Not reported | 0.71 |
| 77 | Nyxoah SA Ordinary Shares | NYXH | 1.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $0.85 | $86,116,087.5 | Not reported | 1.49 |
| 78 | Orchestra BioMed Holdings, Inc. Ordinary Shares | OBIO | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $5.68 | $341,396,678.32 | Not reported | 11.6 |
| 79 | Outset Medical, Inc. Common Stock | OM | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $4.23 | $79,831,085.31 | Not reported | 0.96 |
| 80 | Avita Medical, Inc. Common Stock | RCEL | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $16.59 | $518,730,571.45 | Not reported | Not reported |
| 81 | Senseonics Holdings, Inc. Common Stock | SENS | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $8.59 | $454,188,115.27 | Not reported | 5.03 |
| 82 | Sera Prognostics, Inc. Class A Common Stock | SERA | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.19 | $86,394,330.54 | Not reported | 1.65 |
| 83 | Streamex Corp. Common Stock | STEX | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.34 | $39,481,776.36 | Not reported | 0.27 |
| 84 | Treace Medical Concepts, Inc. Common Stock | TMCI | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $4.03 | $264,205,175.91 | Not reported | 4.29 |
| 85 | Tenon Medical, Inc. Common Stock | TNON | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.64 | $15,494.72 | Not reported | Not reported |
| 86 | Virax Biolabs Group Limited Ordinary Shares | VRAX | 1.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $0.79 | $1,065,096 | Not reported | 0.15 |
| 87 | Adagio Medical Holdings, Inc Common Stock | ADGM | 1 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.06 | $1,441,458.79 | Not reported | Not reported |
| 88 | Advanced Biomed Inc. Common Stock | ADVB | 1 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.98 | $3,271,223.34 | 0.49 | 0.27 |
| 89 | Envoy Medical, Inc. Class A Common Stock | COCH | 1 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $7.15 | $55,373,089.2 | Not reported | Not reported |
| 90 | Solana Company Class A Common Stock (DE) | HSDT | 1 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.93 | $116,685,296.79 | Not reported | 0.69 |
| 91 | ENDRA Life Sciences Inc. Common Stock | NDRA | 1 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $4.73 | $7,094,233.74 | Not reported | 1.12 |
No matching rows. Clear the filter to see all records.
91 companies with eligible ratings and dated fundamentals, from 93 eligible companies in this selection.
Inspect a rated peer
Ratings and dated fundamentals
Lifeward Ltd. Ordinary Shares (LFWD): source evidence dated 2026-11-07T12:42:51.530Z.
- Rank
- 1
- Company
- Intuitive Surgical Inc.
- Ticker
- ISRG
- Rating / 5
- 4
- Report date
- 2025-12-31
- Fiscal period
- 2025 FY
- Model
- anthropic/claude-haiku-5-5
- Market day
- 2026-11-06
The selected ticker, rating, report date and producing model match the first displayed row. Equal ratings use ticker order.
Which recorded peer has the highest usable rating?
The provider's peer set defines membership. It does not establish identical risk or business models. Read report dates and producing models.
NexusTrade stock ratings and report filters- Median market capitalization
- $160,026,172.11 · 91 / 91 displayed companies
- Median positive P/E (TTM)
- 22.01 · 24 / 91 displayed companies
- Median positive price / book
- 2.68 · 82 / 91 displayed companies
- Largest company by market cap
- Intuitive Surgical Inc. (ISRG) · $156,960,275,510.4
- Largest company's share of displayed market cap
- 28.61% · Sum of displayed market caps; not portfolio weights or revenue exposure
Check each median’s included count and each company’s market date. These are unweighted summaries of displayed companies, not a sector index or revenue exposure.
Research LFWD
Open a peer's company view and compare how it actually earns revenue with the anchor company.
Research LFWDKeep reporting dates and units beside the answer, and inspect its original citations.
How these companies are related
Peer membership comes from the same related-company provider used by NexusTrade's stock research. The provider identifies related companies using news coverage and returns data. A related company can be a competitor or a thematic peer; this list does not imply identical products or financial exposure.
Peer membership was fetched 2026-10-12.
The rating determines the order after peer membership is selected. The anchor company is excluded. Companies without an eligible report rating or dated fundamentals are counted in coverage and left out of the ranked table.
What best means in this list
This list was refreshed on 2026-11-07 using existing company reports. The report date in each row is the date of the underlying analysis; refreshing the list does not create a new company report.
Best means the highest stored NexusTrade report ratings within this selection. Ratings use the product's 1-to-5 scale. The list sorts by rating from high to low, with ticker order breaking equal-rating ties. A rating summarizes a report; it does not predict a stock's return.
The peer set comes from the recorded related-company provider. Similarity defines which companies enter this comparison; it does not establish that they have equal business models, risk or expected returns.
What the leading companies do
The first 5 companies below lead the ratings in this snapshot; equal ratings are ordered by ticker. Their company profiles describe different businesses even when they share the Lifeward Ltd. Ordinary Shares (LFWD) selection.
These are company descriptions, not estimates of revenue from this theme. Industry membership does not identify a pure-play business or establish how much sales depend on it. Open the company profile and examine segment disclosures before treating an overlapping classification as equivalent exposure.
Intuitive Surgical Inc. (ISRG): 4 / 5
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.
CONMED Corporation (CNMD): 3.5 / 5
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures in the United States and internationally. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, the company offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention; and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. The company was incorporated in 1970 and is headquartered in Largo, Florida.
DexCom, Inc. (DXCM): 3.5 / 5
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Stelo, a new over-the-counter glucose biosensor designed for adults with prediabetes and Type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
Electromed, Inc. (ELMD): 3.5 / 5
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.
GLOBUS MEDICAL INC (GMED): 3.5 / 5
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers musculoskeletal solutions, including spine products, such as traditional fusion implants, and treatment options for motion preservation technologies, and interventional solutions to treat vertebral compression fractures; orthopedic trauma solutions, which includes fracture plating, intramedullary nailing, and regenerative biologic products; hip and knee joint solutions, including modular hip stems and acetabular cups for total hip arthroplasty, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants; and neuromonitoring services, which provides onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company also offers enabling technologies, such as imaging, navigation, and robotics (INR) solutions for assisted surgery, which includes the ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures with screw and interbody spacer placement applications; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative, image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cell, tissue, and cellular and tissue-based products. The company sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Valuation and company size within this selection
These summaries use the 91 displayed companies. Each company retains its own market observation date in the ratings table above. Medians are unweighted; they are not a sector index valuation.
Positive P/E and price-to-book values are summarized separately. Missing, zero and negative values are excluded from those medians, with the included count shown. A lower multiple alone does not establish better value: profitability, growth, debt and business mix can differ.
Show the table · 5 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Median market capitalization | $160,026,172.11 | 91 / 91 displayed companies |
| Median positive P/E (TTM) | 22.01 | 24 / 91 displayed companies |
| Median positive price / book | 2.68 | 82 / 91 displayed companies |
| Largest company by market cap | Intuitive Surgical Inc. (ISRG) | $156,960,275,510.4 |
| Largest company's share of displayed market cap | 28.61% | Sum of displayed market caps; not portfolio weights or revenue exposure |
No matching rows. Clear the filter to see all records.
Other business classifications in the list
A company can appear in several product and revenue classifications. These overlapping memberships help identify different business mixes to investigate; they are not verified revenue shares or mutually exclusive subindustries.
Show the table · 5 rows, 2 columns
| Additional classification | Matching displayed companies |
|---|---|
| Healthcare | 91 / 91 |
| Medical Devices | 91 / 91 |
| Technology | 79 / 91 |
| Hardware | 78 / 91 |
| Manufacturing | 57 / 91 |
No matching rows. Clear the filter to see all records.
Dates and coverage
Report dates range from 2025-12-31 to 2025-12-31. Market observations range from 2026-11-06 to 2026-11-06. These dates may differ across companies. Daily closes are not synchronized live quotes.
The selection includes 0 companies without a report, 0 with invalid latest rating metadata, 0 with older reports, 2 with missing required fundamentals and 0 with out-of-date market observations. Missing companies receive no substitute score.
How the ranking is built
The ranking uses the latest stored report at or before the refresh cutoff for each active eligible company. The report date, fiscal year/period and producing model remain visible. The latest invalid score is excluded; an older favorable score does not replace it. Publication policy stock-ratings-v1 accepts report ages up to 550 days and market observations up to 10 calendar days, with a positive close and market capitalization. Optional missing ratios remain not reported.
Report ages can differ substantially, particularly between annual and quarterly reports. Different producing models may also use different judgments. Read the date, fiscal period and model before comparing scores. Private report analysis and account data are not published here.
A refresh reads existing reports and market data. It does not rerun a model or create a new analysis. Compare business fundamentals and your own research constraints alongside the score before making a decision.